The overexpression of CCL5 and/or its receptor CCR5 in various tumor cells (e.g. breast cancer,168 acute lymphocytic leukemia,169 multiple myeloma (MM),170 Hodgkin lymphoma,171 colorectal carcinoma172) has long been elucidated. This evidence concerns the gene CCL5 and Hodgkins lymphoma.